1. MARKETS
  2. SECTOR : OTHERS
  3. INDUSTRY : OTHERS
  4. CARIS LIFE SCIENCES INC. - ORDINARY SHARES - CLASS A
Caris Life Sciences Inc. - Ordinary Shares - Class A XNAS: CAI
23.70 -0.91 (-3.70%)
1.3M

XNAS 07 Nov, 2025 1:11 PM (EST)

Watchlist

Portfolio

Alert



Insider Trading disclosures for Caris Life Sciences Inc. - Ordinary Shares - Class A

The latest disclosure was made by Danny Phillips in Caris Life Sciences Inc. - Ordinary Shares - Class A where a trade of 100,000 Common Stock done at an average price of $2.4 was reported to US exchanges on Sept. 11, 2025.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Danny Phillips Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.44 per share. 11 Sep 2025 100,000 116,129 - 2.4 244,000 Common Stock
Danny Phillips Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 11 Sep 2025 100,000 0 - - Stock Option
David Spetzler President Payment of exercise price or tax liability using portion of securities received from the company at price $ 29.75 per share. 11 Aug 2025 63,509 460,377 - 29.8 1,889,393 Common Stock
David D. Halbert Director, See Remarks, Ten Percent Owner Payment of exercise price or tax liability using portion of securities received from the company at price $ 29.75 per share. 11 Aug 2025 141,956 2,295,133 - 29.8 4,223,191 Common Stock
George H. Poste Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.44 per share. 11 Aug 2025 125,000 359,754 - 2.4 305,000 Common Stock
George H. Poste Director Payment of exercise price or tax liability using portion of securities received from the company at price $ 29.75 per share. 11 Aug 2025 91,495 220,237 - 29.7 2,721,976 Common Stock
George H. Poste Director Payment of exercise price or tax liability using portion of securities received from the company at price $ 29.75 per share. 11 Aug 2025 48,022 311,732 - 29.8 1,428,655 Common Stock
George H. Poste Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 11 Aug 2025 125,000 0 - - Stock Option
Brian J. Brille Director, See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Jun 2025 132,428 132,428 - 0 Common Stock
Brian J. Brille Director, See Remarks Purchase of securities on an exchange or from another person at price $ 21.00 per share. 18 Jun 2025 30,000 162,428 - 21 630,000 Common Stock
Luke Power See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Jun 2025 99,321 99,571 - 0 Common Stock
David D. Halbert Director, See Remarks, Ten Percent Owner 25 Mar 2025 29,629,630 0 - - Series B Preferred Stock
David D. Halbert Director, See Remarks, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Mar 2025 360,750 2,023,250 - 0 Common Stock
David D. Halbert Director, See Remarks, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Mar 2025 413,839 2,437,089 - 0 Common Stock
David D. Halbert Director, See Remarks, Ten Percent Owner 25 Mar 2025 104,761,535 121,025,002 - 0 Common Stock
David D. Halbert Director, See Remarks, Ten Percent Owner 25 Mar 2025 389,416,484 0 - - Series A Preferred Stock
David Spetzler President Sale or transfer of securities back to the company at price $ 18.60 per share. 03 Mar 2025 700,509 351,240 - 18.6 13,029,467 Common Stock
David Spetzler President Payment of exercise price or tax liability using portion of securities received from the company at price $ 27.25 per share. 03 Mar 2025 34,782 523,886 - 27.3 947,810 Common Stock
John Russel Denton See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Mar 2025 99,321 116,091 - 0 Common Stock
John Russel Denton See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Mar 2025 255,000 255,000 - - Stock Option
John Russel Denton See Remarks Purchase of securities on an exchange or from another person at price $ 21.00 per share. 03 Mar 2025 7,500 123,591 - 21 157,500 Common Stock
John Russel Denton See Remarks Sale or transfer of securities back to the company at price $ 18.60 per share. 03 Mar 2025 238,230 16,770 - 18.6 4,431,078 Common Stock
David Spetzler President Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Mar 2025 750,000 750,000 - - Stock Option
David Spetzler President Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.44 per share. 03 Mar 2025 75,000 558,668 - 2.4 183,000 Common Stock
David Spetzler President Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Mar 2025 132,428 483,668 - 0 Common Stock
David Spetzler President Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 03 Mar 2025 75,000 0 - - Stock Option
Jon S. Halbert Director 27 Feb 2025 5,000,000 0 - - Series A Preferred Stock
Jon S. Halbert Director 27 Feb 2025 1,250,000 1,250,000 - 0 Common Stock
Jon S. Halbert Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 Feb 2025 16,129 116,129 - 0 Common Stock
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures